FORWARD PURCHASE AGREEMENT Confirmation FOURTH AMENDMENTForward Purchase Agreement • February 22nd, 2024 • NKGen Biotech, Inc. • Biological products, (no disgnostic substances)
THIS FORWARD PURCHASE AGREEMENT CONFIRMATION FOURTH AMENDMENT, dated as of February 21, 2024 (this “Amendment”), is entered into by and among (i) Meteora Capital Partners, LP (“MCP”) (ii) Meteora Select Trading Opportunities Master, LP (“MSTO”) and (iii) Meteora Strategic Capital, LLC (“MSC”) (with MCP, MSTO and MSC collectively as “Seller”) and (v) NKGen Biotech, Inc., a Delaware corporation (“NKGN” and formerly known as Graf Acquisition Corp. IV, a Delaware corporation).
